For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Immunoglobulin Y (abbreviated as IgY) is a type of immunoglobulin which is the major antibody in bird, reptile, and lungfish blood. It is also found in high concentrations in chicken egg yolk. As with the other immunoglobulins, IgY is a class of proteins which are formed by the immune system in reaction to certain foreign substances, and specifically recognize them.
IgY antibodies have a different structure from IgG, particularly in the Fc and hinge regions. The affinity maturation process of IgY is also different from IgG. These biological features underlie IgY's competitive advantages over IgG. Shown in the four panels are several comparisons between IgY and IgG.
IgY is a hen egg polyclonal antibody. Hen eggs contain more than 450 separate antibodies and when consumed, are not rejected by the human immune system.
Scope of the Report:
North America is the largest consumption place, with a consumption market share nearly 37.5% in 2017; Europe is the second largest consumption place with the consumption market share of 30% in 2017.
The worldwide market for IGY Polyclonal Antibodies is expected to grow at a CAGR of roughly 13.5% over the next five years, will reach 9 million US$ in 2024, from 4 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the IGY Polyclonal Antibodies in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
- IGY Life Sciences
- Genway Biotech
- Good Biotech
- Gallus Immunotech
- Creative Diagnostics
- Innovagen AB
- Capra Science
- YO Proteins
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Primary Antibody
- Secondary Antibody
Market Segment by Applications, can be divided into
- Academic Research
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe IGY Polyclonal Antibodies product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of IGY Polyclonal Antibodies, with price, sales, revenue and global market share of IGY Polyclonal Antibodies in 2017 and 2018.
Chapter 3, the IGY Polyclonal Antibodies competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the IGY Polyclonal Antibodies breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, IGY Polyclonal Antibodies market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe IGY Polyclonal Antibodies sales channel, distributors, customers, research findings and conclusion, appendix and data source.